QVT Fund V LP
Insider CIK 1543904 · ACHN 10% owner · AGEN 10% owner · CNCE 10% owner · ABUS Director, 10% owner · AXON 10% owner · MYOV Director, 10% owner · UROV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MYOV Myovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 2,424,242 | $8.25 | $20.00M | 40,765,599 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2018-10-01 | 2018-10-03 | 2,678,571 | $14.00 | $37.50M | 22,703,669 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-06-05 | 2018-06-07 | 14,285,714 | $1.75 | $25.00M | 89,285,714 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2018-04-02 | 2018-04-04 | 1,110,015 | $20.27 | $22.50M | 38,341,357 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2018-01-12 | 2018-01-16 | 664,000 | $100.00 | $66.40M | 1,164,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2017-10-16 | 2017-10-17 | 500,000 | $100.00 | $50.00M | 500,000 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 20,000 | $5.55 | $111.0K | 9,239,260 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 143,900 | $5.30 | $762.7K | 9,095,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 146,394 | $5.27 | $771.5K | 8,948,966 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 53,606 | $5.21 | $279.3K | 8,895,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 400,000 | $5.62 | $2.25M | 8,495,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 41,830 | $5.33 | $223.0K | 6,915,630 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 83,100 | $5.31 | $441.3K | 6,957,460 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 100,000 | $5.35 | $535.0K | 7,040,560 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 89,800 | $5.49 | $493.0K | 7,140,560 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 50,000 | $5.44 | $272.0K | 7,230,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 100,000 | $5.20 | $520.0K | 7,280,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 43,080 | $5.57 | $240.0K | 7,380,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 856,920 | $5.18 | $4.44M | 7,423,440 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 215,000 | $5.19 | $1.12M | 8,280,360 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 219,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 250,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 259,999 | — | $0 | 259,999 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 300,000 | $14.00 | $4.20M | 559,999 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 254,900 | $3.43 | $874.3K | 14,212,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 2,250,000 | $3.50 | $7.88M | 11,962,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 250,000 | $3.27 | $817.5K | 11,712,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-08-09 | 2013-08-12 | 65,982 | $6.37 | $420.3K | 14,467,853 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-08-08 | 2013-08-12 | 36,300 | $6.48 | $235.2K | 14,401,871 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-11 | 2013-07-15 | 341,355 | $6.46 | $2.21M | 14,305,909 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-11 | 2013-07-15 | 59,662 | $6.47 | $386.0K | 14,365,571 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-10 | 2013-07-11 | 90,944 | $6.38 | $580.2K | 13,964,554 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-10 | 2013-07-11 | 100,000 | $6.35 | $635.0K | 13,873,610 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-09 | 2013-07-11 | 200,000 | $6.30 | $1.26M | 13,773,610 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-08 | 2013-07-09 | 445,209 | $6.30 | $2.80M | 13,573,610 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-05 | 2013-07-09 | 72,300 | $6.21 | $449.0K | 13,128,401 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-05 | 2013-07-09 | 125,000 | $6.26 | $782.5K | 13,056,101 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-03 | 2013-07-05 | 442,737 | $6.24 | $2.76M | 12,931,101 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-03 | 2013-07-05 | 20,511 | $6.32 | $129.6K | 12,488,364 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-02 | 2013-07-05 | 1,300,000 | $6.51 | $8.46M | 12,467,853 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-02 | 2013-07-05 | 150,000 | $6.30 | $945.0K | 11,167,853 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-02 | 2013-07-05 | 50,000 | $6.31 | $315.5K | 11,017,853 | SEC↗ |